cytarabine and its Impurities

Cytarabine is mainly used in the treatment of acute myeloid leukaemia, acute lymphocytic leukaemia and in lymphomas, where it is the backbone of induction chemotherapy.. Reference standards of Cytarabine API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below

Displaying 20 results for cytarabine Impurities
Drug Reference Standards & Impurity Synthesis in India
PA 56 46000

Cytarabine

Cytarabine


  • Catalogue No.:PA 56 46000

  • CAS :

    147-94-4

  • Molecular Formula : C9H13N3O5

  • Molecular Weight : 243.22

Drug Reference Standards & Impurity Synthesis in India
PA 56 46010

Cytarabine - Impurity A

Uracil Arabinoside


  • Catalogue No.:PA 56 46010

  • CAS :

    3083-77-0

  • Molecular Formula : C9H12N2O6

  • Molecular Weight : 244.2

Drug Reference Standards & Impurity Synthesis in India
PA STI 023990

Cytarabine-13C3

Cytarabine-13C3


  • Catalogue No.:PA STI 023990

  • CAS :

    NA

  • Molecular Formula : C613C3H13N3O5

  • Molecular Weight : 246.19

Drug Reference Standards & Impurity Synthesis in India
PA STI 024000

Cytarabine-13C3 5'-Monophosphate

Cytarabine-13C3 5'-Monophosphate


  • Catalogue No.:PA STI 024000

  • CAS :

    NA

  • Molecular Formula : C613C3H14N3O8P

  • Molecular Weight : 326.17

Drug Reference Standards & Impurity Synthesis in India
PA STI 036130

Dodecyl Phthalate-d4

Dodecyl Phthalate-d4


  • Catalogue No.:PA STI 036130

  • CAS :

    2732763-22-1

  • Molecular Formula : C20H26D4O4

  • Molecular Weight : 338.47

Drug Reference Standards & Impurity Synthesis in India
PA BP383RB

cytarabine (383RB)

cytarabine (383RB)


  • Catalogue No.:PA BP383RB

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA ICRS46472

Cytarabine (ICRS46472)

Cytarabine (ICRS46472)


  • Catalogue No.:PA ICRS46472

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA EPC3350000

Cytarabine (C3350000)

Cytarabine (C3350000)


  • Catalogue No.:PA EPC3350000

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA EPU0100000

Uracil arabinoside (U0100000)

Uracil arabinoside (U0100000)


  • Catalogue No.:PA EPU0100000

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA IPIPRS 134 12

Cytarabine (IPRS/134/12)-from IPC

Cytarabine (IPRS/134/12)-from IPC


  • Catalogue No.:PA IPIPRS 134 12

  • CAS :

    NA

  • Molecular Formula : NA

  • Molecular Weight : NA

Drug Reference Standards & Impurity Synthesis in India
PA 56 0461000

4-Amino-1-((2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one

4-Amino-1-((2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidin-2(1H)-one


  • Catalogue No.:PA 56 0461000

  • CAS :

    13913-16-1

  • Molecular Formula : C9H13N3O5

  • Molecular Weight : 243.22

Drug Reference Standards & Impurity Synthesis in India
PA 56 0461001

3-Carbamoyl-1-((2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyridin-1-ium Chloride

3-Carbamoyl-1-((2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyridin-1-ium Chloride


  • Catalogue No.:PA 56 0461001

  • CAS :

    72521-19-8

  • Molecular Formula : C11H15ClN2O5

  • Molecular Weight : 290.7

Drug Reference Standards & Impurity Synthesis in India
PA 56 0461002

2,3,5-Triacetyl-α-nicotinamide-D-ribofuranose Chloride

2,3,5-Triacetyl-α-nicotinamide-D-ribofuranose Chloride


  • Catalogue No.:PA 56 0461002

  • CAS :

    2225980-94-7

  • Molecular Formula : C17H21ClN2O8

  • Molecular Weight : 416.81

Drug Reference Standards & Impurity Synthesis in India
PA 56 0460090

Cytarabine - Impurity I

4-Amino-1-β-D-arabinofuranosyl-5-methylpyrimidin-2(1H)-one


  • Catalogue No.:PA 56 0460090

  • CAS :

    6829-31-8

  • Molecular Formula : C10H15N3O5

  • Molecular Weight : 257.25

Drug Reference Standards & Impurity Synthesis in India
PA 56 0460060

Cytarabine - Impurity F

4-Amino-1-(2,5-anhydro-ß-D-arabinofuranosyl)pyrimidin-2(1H)-one


  • Catalogue No.:PA 56 0460060

  • CAS :

    32830-01-6

  • Molecular Formula : C9H11N3O4

  • Molecular Weight : 225.2

Drug Reference Standards & Impurity Synthesis in India
PA 56 0460070

Cytarabine - Impurity G

5-Methylcytidine


  • Catalogue No.:PA 56 0460070

  • CAS :

    2140-61-6

  • Molecular Formula : C10H15N3O5

  • Molecular Weight : 257.25

Drug Reference Standards & Impurity Synthesis in India
PA 56 0460080

Cytarabine - Impurity H

(2R,3R,3aS,9aR)-2-(Hydroxymethyl)-6-imino-2,3,3a,9a-tetrahydro-6H-furo[2′,3′:4,5][1,3]oxazolo[3,2-a]pyrimidin-3-ol


  • Catalogue No.:PA 56 0460080

  • CAS :

    31698-14-3

  • Molecular Formula : C9H11N3O4

  • Molecular Weight : 225.2

Drug Reference Standards & Impurity Synthesis in India
PA 56 0460081

Cytarabine - Impurity H (Hydrochloride Salt)

(2R,3R,3aS,9aR)-2-(Hydroxymethyl)-6-imino-2,3,3a,9a-tetrahydro-6H-furo[2′,3′:4,5][1,3]oxazolo[3,2-a]pyrimidin-3-ol Hydrochloride


  • Catalogue No.:PA 56 0460081

  • CAS :

    10212-25-6

  • Molecular Formula : C9H12ClN3O4

  • Molecular Weight : 261.66

Drug Reference Standards & Impurity Synthesis in India
PA 56 0461003

4-Carbamoyl-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyridin-1-ium Chloride

4-Carbamoyl-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyridin-1-ium Chloride


  • Catalogue No.:PA 56 0461003

  • CAS :

    NA

  • Molecular Formula : C11H15ClN2O5

  • Molecular Weight : 290.7

Drug Reference Standards & Impurity Synthesis in India
PA 56 0461004

3-Carboxy-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyridin-1-ium Chloride

3-Carboxy-1-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyridin-1-ium Chloride


  • Catalogue No.:PA 56 0461004

  • CAS :

    NA

  • Molecular Formula : C11H14ClNO6

  • Molecular Weight : 291.68

pharmaffiliates